Search Results

Pain sensation and the emotional experience of pain are not the same, and now, in mice, scientists at Stanford have found the neurons responsible for the latter.

In mouse studies, a Stanford-led team has developed an engineered immune cell that eliminates several types of childhood tumors. The innovation may help patients with relapsed or metastatic disease.

Physical therapy within three months of a musculoskeletal pain diagnosis reduced patients’ risk of long-term opioid use by about 10 percent, according to a study by researchers at Stanford and Duke.

The report finds a rapid increase in the volume and utility of health-related data, creating an opportunity to democratize health care.

Three types of cells in the brain’s white matter show interwoven problems during the cognitive dysfunction that follows treatment with the cancer drug methotrexate, Stanford neuroscientists have found.

A lowly sea creature may provide a way to understand our own blood-forming system, improve our immune function and find new immune-associated tools for biological discovery, Stanford researchers say.

An active protein component of royal jelly helps honeybees create new queens. Stanford researchers have identified a similar protein in mammals, which keeps cultured embryonic stem cells pluripotent.

Fibrous adhesions that form after abdominal surgery may be preventable or treatable, according to Stanford study. Adhesions affect most surgical patients, and treating them costs over $1 billion annually.

In trying to decipher the “DNA origami” responsible for the generation of transplantable human skin, Stanford researchers have uncovered a master regulatory hierarchy controlling tissue differentiation.

An immunotherapy conceived at Stanford appeared safe in an early clinical trial. Half of the participants responded positively to the treatment, aimed at triggering macrophages to engulf cancer cells, the researchers reported.